Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Dicato

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Mitochondrion|June 28, 2012
Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosidesClaudia Cerella, Mario Dicato, Marc Diederich
Frontiers in Oncology|August 24, 2013
Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure CancerFrançois Gaascht, Mario Dicato, Marc Diederich
Annals of the New York Academy of Sciences|April 4, 2007
Effect of curcumin treatment on protein phosphorylation in K562 cellsRomain Blasius, Mario Dicato, Marc Diederich
Biochemical Pharmacology|January 8, 2019
Natural modulators of the hallmarks of immunogenic cell deathFlavia Radogna, Mario Dicato, Marc Diederich
Trends in Pharmacological Sciences|October 9, 2020
BH3 Mimetics in AML Therapy: Death and Beyond?Claudia Cerella, Mario Dicato, Marc Diederich
Biotechnology Advances|April 5, 2014
Plant-derived epigenetic modulators for cancer treatment and preventionMichael Schnekenburger, Mario Dicato, Marc Diederich
Biochemical Pharmacology|January 7, 2015
Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological targetFlavia Radogna, Mario Dicato, Marc Diederich
Pharmacological Research|September 15, 2023
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targetingClaudia Cerella, Mario Dicato, Marc Diederich
Cancer|March 7, 2019
Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?Michael Schnekenburger, Mario Dicato, Marc F Diederich
Molecules (Basel, Switzerland)|December 17, 2014
Hybrid curcumin compounds: a new strategy for cancer treatmentMarie-Hélène Teiten, Mario Dicato, Marc Diederich
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Mitochondrion|June 28, 2012
Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosidesClaudia Cerella, Mario Dicato, Marc Diederich
Frontiers in Oncology|August 24, 2013
Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure CancerFrançois Gaascht, Mario Dicato, Marc Diederich
Annals of the New York Academy of Sciences|April 4, 2007
Effect of curcumin treatment on protein phosphorylation in K562 cellsRomain Blasius, Mario Dicato, Marc Diederich
Biochemical Pharmacology|January 8, 2019
Natural modulators of the hallmarks of immunogenic cell deathFlavia Radogna, Mario Dicato, Marc Diederich
Trends in Pharmacological Sciences|October 9, 2020
BH3 Mimetics in AML Therapy: Death and Beyond?Claudia Cerella, Mario Dicato, Marc Diederich
Biotechnology Advances|April 5, 2014
Plant-derived epigenetic modulators for cancer treatment and preventionMichael Schnekenburger, Mario Dicato, Marc Diederich
Biochemical Pharmacology|January 7, 2015
Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological targetFlavia Radogna, Mario Dicato, Marc Diederich
Pharmacological Research|September 15, 2023
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targetingClaudia Cerella, Mario Dicato, Marc Diederich
Cancer|March 7, 2019
Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?Michael Schnekenburger, Mario Dicato, Marc F Diederich
Molecules (Basel, Switzerland)|December 17, 2014
Hybrid curcumin compounds: a new strategy for cancer treatmentMarie-Hélène Teiten, Mario Dicato, Marc Diederich
Pageof 16